Note 8 - Accounts Receivable |
9 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 | |||||||||||||||||||||||||||||||||||||
| Accounts Receivable [Member] | |||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | |||||||||||||||||||||||||||||||||||||
| Accounts and Nontrade Receivable [Text Block] |
Note 8. Accounts Receivable
Accounts receivable consisted of the following (in thousands):
The Company decreased the allowance for credit losses in the amount of approximately $0.1 million and $12,000 for the nine months ended September 30, 2024 and 2023, respectively.
Accounts receivable – trade, net for the Company as of January 1, 2023 and September 30, 2023 were approximately $0.4 million and $7.8 million, respectively.
|
||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|